Oklahoma Senate Bill SB370

Oklahoma 2022 Regular Session

• Introduced: 2/1/21
• Refer: 2/2/21

Caption

Pharmacy; requiring State Board of Pharmacy to ensure certain compliance with manufacturer guidelines. Effective date.

Impact

The implications of SB370 will significantly enhance the regulatory framework governing pharmacies in Oklahoma. This includes a stronger emphasis on the enforcement of guidelines related to drug handling and storage. By holding pharmacies accountable for adhering to manufacturer guidelines, the bill aims to mitigate health risks associated with improper drug management, ultimately aiming to ensure that consumers receive medications that are both safe and effective.

Summary

Senate Bill 370 seeks to amend the Oklahoma Pharmacy Act specifically regarding the powers and duties of the State Board of Pharmacy. The bill mandates that the Board ensure compliance with manufacturer guidelines, particularly in relation to the shipping, storage, and dispensation of drugs. By establishing these compliance measures, SB370 aims to enhance the safety and efficacy of medication distribution within the state, thereby protecting public health by aligning pharmacy operations with best practices and regulatory standards.

Contention

While SB370 may garner support from health advocates who prioritize patient safety and regulatory compliance, there may be voices of dissent from pharmacy practitioners concerned about the feasibility of heightened regulatory expectations. Critics might argue that such stringent measures could impose additional operational burdens on pharmacies, especially smaller, independent ones. The need for resources to implement compliance measures and potential fines for violations could also be contentious points raised during discussions around the bill.